In India there are only three players in this field
Dr Reddy’s
BioCon (BioCon is aggressively pursuing biosimilars)
Intas
As biosimilars production is extremely complex task/process, I am guessing we wont see other Indian companies jumping into it.
According to a report biosimilar market would around 20 billion by 2020. I request other members to share their views.
| Subscribe To Our Free Newsletter |
